Cellular Genomics Raises $34.9M in Series C

Cellular Genomics said this week it has raised $34.9 million in a Series C private equity financing round.

The Branford, Conn.-based company, which applies its chemical genetics platform for in-house drug discovery and in collaborations, said it plans to use the funding to advance the in-house programs into the clinic.

In this round, previous investors Coastview Capital and Connecticut Innovations were joined by new investors CDP Capital, RiverVest Venture Partners, and Toucan Capital.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.